Patent · US Active

Cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus

US9439908B2 · kind B2 · utility

10Cited by

0References

11Claims

0Family size

Assignee

SOOFT ITALIA SPA · IT

Inventors

Fulvio Foschini · Roma, IT
Marcello Stagni · Catania, IT
Giulio Luciani · Bagno a Ripoli, IT
Pierre Roy · Paris, FR

Key dates

Filing date	Oct 24, 2012
Grant date	Sep 13, 2016
Priority date	—
Expiry date	Jan 8, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An improved formulation of an ophthalmic composition contains riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the treatment of keratoconus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.